153 related articles for article (PubMed ID: 9247774)
1. High-dose torasemide, given once daily intravenously for one week, in patients with advanced chronic renal failure.
Boesken WH; Kult J
Clin Nephrol; 1997 Jul; 48(1):22-8. PubMed ID: 9247774
[TBL] [Abstract][Full Text] [Related]
2. Single dose comparison of torasemide and furosemide in patients with advanced renal failure.
Klütsch K; Grosswendt J; Haecker W
Arzneimittelforschung; 1988 Jan; 38(1A):200-4. PubMed ID: 3285834
[TBL] [Abstract][Full Text] [Related]
3. Comparison of efficacy and tolerance of different oral doses of torasemide and furosemide in patients with advanced chronic renal failure.
Kult J; Häcker W; Glocke M
Arzneimittelforschung; 1988 Jan; 38(1A):212-4. PubMed ID: 3285837
[TBL] [Abstract][Full Text] [Related]
4. Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure.
Fliser D; Schröter M; Neubeck M; Ritz E
Kidney Int; 1994 Aug; 46(2):482-8. PubMed ID: 7967362
[TBL] [Abstract][Full Text] [Related]
5. Torasemide in advanced renal failure.
Kindler J
Cardiovasc Drugs Ther; 1993 Jan; 7 Suppl 1():75-80. PubMed ID: 8435381
[TBL] [Abstract][Full Text] [Related]
6. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
[TBL] [Abstract][Full Text] [Related]
7. Renal excretory responses to single and repeated administration of diuretics in healthy subjects: clinical connotations.
Reyes AJ; Leary WP
Cardiovasc Drugs Ther; 1993 Jan; 7 Suppl 1():29-44. PubMed ID: 8435375
[TBL] [Abstract][Full Text] [Related]
8. Dose-dependent salidiuretic efficacy of torasemide in comparison to furosemide and placebo in advanced renal failure.
Mourad G; Haecker W; Mion C
Arzneimittelforschung; 1988 Jan; 38(1A):205-8. PubMed ID: 3285835
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the pharmacokinetics and diuretic effects of two loop diuretics, torasemide and furosemide, in normal volunteers.
Dodion L; Ambroes Y; Lameire N
Eur J Clin Pharmacol; 1986; 31 Suppl():21-7. PubMed ID: 3780837
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of torasemide in congestive heart failure.
Kramer WG
Cardiology; 1994; 84 Suppl 2():108-14. PubMed ID: 7954532
[TBL] [Abstract][Full Text] [Related]
11. Diuretic activity of torasemide and furosemide in chronic heart failure: a comparative double blind cross-over study.
Scheen AJ; Vancrombreucq JC; Delarge J; Luyckx AS
Eur J Clin Pharmacol; 1986; 31 Suppl():35-42. PubMed ID: 3780838
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of intravenous trasemide in mutant Nagase analbuminemic rats.
Kim EJ; Lee MG
Biopharm Drug Dispos; 2003 Jan; 24(1):27-35. PubMed ID: 12516076
[TBL] [Abstract][Full Text] [Related]
13. Torasemide, a new loop diuretic, in patients with chronic renal failure.
Russo D; Gazzotti RM; Testa A
Nephron; 1990; 55(2):141-5. PubMed ID: 2194134
[TBL] [Abstract][Full Text] [Related]
14. Torasemide. A review of its pharmacological properties and therapeutic potential.
Friedel HA; Buckley MM
Drugs; 1991 Jan; 41(1):81-103. PubMed ID: 1706990
[TBL] [Abstract][Full Text] [Related]
15. Saluretic effect of the loop diuretic torasemide in chronic renal failure. Interdependence of electrolyte excretion.
Knauf H; Mutschler E
Eur J Clin Pharmacol; 1990; 39(4):337-43. PubMed ID: 2076714
[TBL] [Abstract][Full Text] [Related]
16. Liver cirrhosis with ascites: pathogenesis of resistance to diuretics and long-term efficacy and safety of torasemide.
Knauf H; Mutschler E
Cardiology; 1994; 84 Suppl 2():87-98. PubMed ID: 7954550
[TBL] [Abstract][Full Text] [Related]
17. Acute and chronic effects of torasemide in healthy volunteers.
Lameire N; Dodion L
Arzneimittelforschung; 1988 Jan; 38(1A):167-71. PubMed ID: 3370064
[TBL] [Abstract][Full Text] [Related]
18. Diuretic activity, safety and pharmacokinetics of torasemide during chronic treatment in normal subjects.
Ambroes Y; Ronflette I; Dodion L
Eur J Clin Pharmacol; 1986; 31 Suppl():1-7. PubMed ID: 3780835
[TBL] [Abstract][Full Text] [Related]
19. Torasemide for diuretic treatment of advanced chronic renal failure.
Clasen W; Khartabil T; Imm S; Kindler J
Arzneimittelforschung; 1988 Jan; 38(1A):209-11. PubMed ID: 3285836
[TBL] [Abstract][Full Text] [Related]
20. Advantages of the new loop diuretic torasemide over furosemide in patients with cirrhosis and ascites. A randomized, double blind cross-over trial.
Gerbes AL; Bertheau-Reitha U; Falkner C; Jüngst D; Paumgartner G
J Hepatol; 1993 Mar; 17(3):353-8. PubMed ID: 8315263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
